Skip to main content
OpenTrials
Completed

NCT Number: NCT05289544

Phone-Based Based Walk With Ease Program for Adults With Arthritis

The objective of this study is to examine the short-term (6-weeks and 6 months) and long-term (1 year) effects of a phone-based version of Walk With Ease intervention.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Participants will be randomized to either start the 6-week program immediately or after one year. Our Walk with Ease by Telephone (WWE-T) program is adapted from the original 6-week community-based group walking program developed by the Arthritis Foundation for adults with arthritis. The phone-based program will include 2 phone calls each week with a trained Walk With Ease Leader for 6 weeks. Assessments will be completed before at the start of the study, 6 weeks, 6 months and at 12 months.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • told by a doctor or other health professional that you have some form of arthritis, rheumatoid arthritis, gout, lupus, fibromyalgia
  • able to read and write in English
  • plan to live in the Columbia, SC region for next year
  • willing to be randomized to either group
  • complete all baseline measure

Exclusion criteria

  • contraindications to exercise (besides arthritis)
  • are pregnant, breastfeeding, or planning to become pregnant in the next year
  • have a serious cognitive impairment

Treatment and study plan

Phone-Based Walk With Ease

Behavioral

6 week phone-delivered Walk With Ease Program

Primary outcomes

  1. Change in Pain

    Time frame: Baseline to 6 weeks

    Visual analog scale (0mm no/low pain to 100 mm high pain)

  2. Change in Pain

    Time frame: Baseline to 6 months

    Visual analog scale (0mm no/low pain to 100 mm high pain)

  3. Change in Pain

    Time frame: Baseline to 12 months

    Visual analog scale (0mm no/low pain to 100 mm high pain)

  4. Change in Physical Function - Chair Stands

    Time frame: Baseline to 6 weeks

    repetitions completed during 30 second chair stand test

  5. Change in Physical Function - Chair Stands

    Time frame: Baseline to 6 months

    repetitions completed during 30 second chair stand test

  6. Change in Physical Function - Chair Stands

    Time frame: Baseline to 12 months

    repetitions completed during 30 second chair stand test

  7. Change in Physical Function - 6 Minute Walk

    Time frame: Baseline to 6 weeks

    Distance walked (ft) during 6 minute walk test

  8. Change in Physical Function - 6 Minute Walk

    Time frame: Baseline to 6 months

    Distance walked (ft) during 6 minute walk test

  9. Change in Physical Function - 6 Minute Walk

    Time frame: Baseline to 12 months

    Distance walked (ft) during 6 minute walk test

Secondary outcomes

  1. Change in Physical Limitations

    Time frame: Baseline to 6 weeks

    Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability

  2. Change in Physical Limitations

    Time frame: Baseline to 6 months

    Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability

  3. Change in Physical Limitations

    Time frame: Baseline to 12 months

    Health Assessment Questionnaire (HAQ) - Total score ranging from 0-3, with a higher score indicating more impairment or disability

  4. Change in Physical Activity

    Time frame: Baseline to 6 weeks

    total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors

  5. Change in Physical Activity

    Time frame: Baseline to 6 months

    total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors

  6. Change in Physical Activity

    Time frame: Baseline to 12 months

    total moderate and vigorous intensity physical activity (>=2020 cpm) measured by Actigraph GT3x Link activity monitors

  7. Change in Arthritis Management Self-efficacy

    Time frame: Baseline to 6 weeks

    Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis

  8. Change in Arthritis Management Self-efficacy

    Time frame: Baseline to 6 months

    Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis

  9. Change in Arthritis Management Self-efficacy

    Time frame: Baseline to 12 months

    Confidence to manage symptoms of arthritis assessed by the Arthritis Self-Efficacy Scale. Total score 0-10 with higher scores indicating higher levels of self-efficacy for managing arthritis

  10. Change in Blood Pressure

    Time frame: Baseline to 6 weeks

    Diastolic blood pressure measured in mmHg

  11. Change in Blood Pressure

    Time frame: Baseline to 6 months

    Diastolic blood pressure measured in mmHg

  12. Change in Blood Pressure

    Time frame: Baseline to 12 months

    Diastolic blood pressure measured in mmHg

Sponsors and collaborators

Lead sponsor

University of South Carolina

Other

Registry information

Official study title

Evaluating Alternative Delivery Models for Arthritis Self-management Interventions

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Mar 21, 2022
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.